Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease
NCT04394117
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
787
Enrollment
OTHER
Sponsor class
Conditions
Coronavirus Disease 2019
COVID-19
Interventions
DRUG:
Angiotensin Receptor Blockers
OTHER:
Placebo
Sponsor
The George Institute